Friday, July 04, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Public Companies : Healthcare/BioTech


Bio-Rad to Report First-Quarter 2008 Financial Results Tuesday, May 6, 2008

Apr 11, 2008 - 12:36:01 PM

News Source MARKET WIRE

Email this article
 Printer friendly page
HERCULES, CA -- (MARKET WIRE) -- 04/11/08 -- Bio-Rad Laboratories, Inc. (AMEX: BIO) and(AMEX: BIOb), a multinational manufacturer and distributor of life scienceresearch and clinical diagnostic products, will report financial resultsfor the first quarter 2008 on Tuesday, May 6, 2008, after the close of themarket. The company will discuss these results in a conference callscheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

Interested parties may access the call by dialing 800-599-9829 (in theU.S.) or 617-847-8703 (international), access number 53867766. The livewebcast can be accessed at http://www.bio-rad.com. A replay of the callwill be available at 888-286-8010 (in the U.S.), or 617-801-6888(international), access number 44990505 for seven days following the call,and the webcast can be accessed at http://www.bio-rad.com for 30 days.

About Bio-Rad

Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb) has remained at thecenter of scientific discovery for more than 50 years manufacturing anddistributing a broad range of products for the life science research andclinical diagnostic markets. The company is renowned worldwide amonghospitals, universities, major research institutions, as well asbiotechnology and pharmaceutical companies for its commitment to qualityand customer service. Founded in 1952, Bio-Rad is headquartered inHercules, California, and serves more than 85,000 research and industrycustomers worldwide through its global network of operations. The companyemploys over 6,300 people globally and had revenues approaching $1.5billion in 2007. For more information, visit www.bio-rad.com.

This release contains certain forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995 and Section 21E ofthe Securities Exchange Act of 1934. Forward-looking statements generallycan be identified by the use offorward-looking terminology such as, "believe," "expect," "may," "will,""intend," "estimate," "continue," or similar expressions or the negative ofthose terms or expressions. Such statements involve risks anduncertainties, which could cause actual results to vary materially fromthose expressed in or indicated by the forward-looking statements. Forfurther information regarding the Company's risks and uncertainties, pleaserefer to the "Risk Factors" in the Company's public reports filed with theSecurities and Exchange Commission, including the Company's Annual Reporton Form 10-K for the fiscal year ended December 31, 2007, as updated bysubsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.The Company cautions you not to place undue reliance on forward-lookingstatements, which reflect an analysis only and speak only as of the datehereof. Bio-Rad Laboratories, Inc. disclaims any obligation to updatethese forward-looking statements.

For more information contact:
Christine Tsingos
Vice President and Chief Financial Officer
or
Ron Hutton
Treasurer
Bio-Rad Laboratories, Inc.
510-724-7000
Email Contact



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
MediSys Corporation Engages Corporate Finance Team
Smith & Nephew Plc - Transaction in Own Shares
On National HIV Testing Day Chembio Reports Completion of Pediatric Study Needed for Expanded Product Usage
Ambrilia Announces Executive Departure
Medical Nutrition USA, Inc. Appoints Scientific Director
Warnex Launches New Paternity Testing Website: www.prodna.ca
UCB's Vimpat(TM) recommended for approval in Europe for epilepsy
Smith & Nephew PLC - Transaction in Own Shares
Smith & Nephew Plc - Holding(s) in Company
AspenBio Pharma Commences FDA Clinical Trial for AppyScore(TM) Appendicitis Blood Test